The largest database of trusted experimental protocols

Centrifree ym 30

Manufactured by Merck Group
Sourced in United States, Germany

The Centrifree YM-30 is a laboratory centrifugal device. It is used for the filtration and separation of macromolecules and other components in liquid samples.

Automatically generated - may contain errors

16 protocols using centrifree ym 30

1

Serum Thyroid Hormone Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples were thawed at room temperature. After that, 400 µL of serum sample was placed in a 30 kDa ultrafiltration device (Centrifree YM-30, Millipore) and centrifuged in at 2700 rpm at 37°C for 30 min. Next, 150 µL of ultrafiltrate
mixed with 450 µL methanol containing internal standards, deuterium-labeled T4, and carbon-labeled T3 for deproteinization. Vortex the mixture for the 30s and centrifuged for 10 min at 13,000 rpm. Next, 500 µL of supernatant was diluted with
600 µL of distilled de-ionized water, and 400 µL of an aliquot from them was injected onto a Phenomenex Kinetex 2.6 µm C18 column (73 x 2.2 mm). After washing, the analyze compounds were eluted from the column with a water/methanol gradient
into the MS/MS system [21 (link)].
+ Open protocol
+ Expand
2

Quantification of Thyroid Hormones in Serum

Check if the same lab product or an alternative is used in the 5 most similar protocols
This method was performed in the Department of Laboratory Medicine at the National Institutes of Health, Bethesda, MD. The updated method was similar to our previous method [20 (link),21 (link)], with minor modifications. Human serum/plasma samples were thawed at room temperature. 400 µL of human serum/plasma was placed in a 30 kDa ultrafiltration device (Centrifree YM-30, Millipore) and centrifuged in an Eppendorf temperature controlled centrifuge with a fixed angle rotor at 2700 rpm and a temperature of 37 °C for 30 min. To a 1.5 mL conical plastic Eppendorf centrifuge tube, 150 µL of ultrafiltrate was added and mixed with 450 µL methanol containing internal standards, deuterium-labeled T4 (T4-d5) and carbon-labeled T3 (T3-13C6), for deproteinization. The tube was capped, vortex mixed vigorously for 30 s, and centrifuged for 10 min at 13,000 rpm. After centrifugation, 500 µL of supernatant was diluted with 600 µL of distilled de-ionized water and 400 µL aliquot was injected onto a Phenomenex Kinetex 2.6 µm C18 column (75 × 2.1 mm). The procedure involved an online extraction step followed by activation of a built-in valco switching valve and subsequent sample introduction into the mass spectrometer. After washing, the switching valve was activated and the analyte compounds were eluted from the column with a water/methanol gradient into the MS/MS system (see Table 1a).
+ Open protocol
+ Expand
3

Estimating Unbound Drug Fraction in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
An ultrafiltration method was used to estimate the free (unbound) fraction in plasma (fu (plasma)). Radiolabeled drug (50 μL) was added to monkey plasma (500 μL) or saline (for control, 500 μL), and the resulting mixture was incubated at room temperature for 10 minutes. After incubation, 200-μL portions of the incubation mixtures were pipetted into ultrafiltration tubes (Centrifree YM-30, molecular weight cutoff, 30000; Millipore) and centrifuged at 1500 g for 15 minutes. Equal aliquots (20 μL) of ultrafiltrate (Cfree) and plasma (Ctotal) were measured for their radioactivity with a NaI well-counter. Each determination was performed in duplicate. fu (plasma) was calculated as Cfree/Ctotal, and the results were corrected for the membrane binding measured in control samples.
+ Open protocol
+ Expand
4

Oral Gavage of 14C-Tasquinimod in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were orally gavaged with 14C-labeled tasquinimod at a dose of 5mg/kg and 1 hour later blood collected and plasma isolated and the PBF determined as described previously [40 ] using Centrifree® YM-30 centrifuge filter unit with a molecular weight cutoff of 30K (i.e., Millipore, Billerica,MO).
+ Open protocol
+ Expand
5

Measuring Plasma Protein Binding of Radioligands

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma protein binding of all
three radioligands was measured in duplicate in baseline conditions.
NHP blood plasma (500 μL) and a PBS solution (pH 7.4, KCl 0.2
mg, KH2PO4 0.2 mg, Na2HPO4 1.42 mg, NaCl 8 mg in 1 mL) were mixed with the respective radioligand
(50 μL, approx. 20 MBq in PBS). The plasma mixture was incubated
for 10 min at room temperature and a small portion (20 μL) from
each incubation mixture was measured in a well counter. A portion
(200 μL) from all individual incubation mixtures was pipetted
out into ultrafiltration tubes (Millipore Centrifree YM-30) and centrifuged
at 3000 rpm for 15 min. Samples (20 μL) from each filtrate were
counted in a well counter. The following formula was used to calculate
the protein-bound fraction. where Cpla (total) is the radioactivity concentration
of the incubation mixture in
plasma, CPBS (total) is the radioactivity
concentration of the incubation mixture in PBS, and Cpla (filtrate) and Cpla (filtrate) are the radioactivity concentrations from filtrate samples.
+ Open protocol
+ Expand
6

Measuring Free Fraction in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
The free fraction (fp) in blood plasma was measured using an ultrafiltration method [30 (link)] with the blood sample collected before the injection of [11C]PF06885190. Plasma (0.4 mL) was mixed with [11C]PF06885190 formulation (0.04 mL, ~1 MBq) and incubated at room temperature (RT) for 10 min. To estimate the non-specific binding percent, the same process was performed on phosphate buffered saline (PBS) (0.4 mL) as a control solution. After the incubation, 0.2 mL of the plasma and PBS incubated mixtures were pipetted into ultrafiltration tubes (Centrifree YM-30, molecular weight cutoff, 30,000 Da; Millipore: Billerica, MA, USA) and centrifuged at 3800 rpm for 15 min. Equal aliquots (0.02 mL) of the ultrafiltrate (Cfree) and the plasma (Ctotal) were counted for their radioactivity with a NaI well-counter. Each determination was performed in triplicate. The free fraction was then calculated as fp = Cfree/Ctotal, and the results were corrected for the membrane binding measured with the control samples.
+ Open protocol
+ Expand
7

Protein Binding of Cefiderocol in Humans and Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
The protein binding values of cefiderocol in humans and rats were determined by the ultrafiltration method. Briefly, cefiderocol dissolved in phosphate-buffered saline (PBS) (pH 7.4) was added to freshly collected human or rat plasma to prepare a 10-μg/ml test sample. The test sample was incubated at 37°C in a water bath for 15 min and was dispensed into ultrafiltration devices (Centrifree YM-30; Millipore, Bedford, MA). After centrifugation for 15 min at 37°C and 1,800 × g, the filtrate was collected. The protein binding ratio was calculated from the cefiderocol concentrations in the test sample before centrifugation and in the filtrate after centrifugation. The protein binding values in humans and rats were 58% and 47%, respectively. The protein binding values of CAZ in humans and rats (21% and 20%, respectively) were taken from the literature (31 ).
+ Open protocol
+ Expand
8

Measuring Free Fraction of Radiometabolite

Check if the same lab product or an alternative is used in the 5 most similar protocols
The free fraction of radiometabolite in blood plasma was measured by ultrafiltration method, as described in our previous method [10 ]. Briefly, a blood sample was drawn a few minutes before injection of [18F]AZ10419096. Then plasma (300 μL) or phosphate buffered saline solution (300 μL) as a control were mixed with [18F]AZ10419096 (30 μL) and incubated at room temperature for 10 min. After the incubation, 200 μL portions of the incubation mixtures were pipetted into ultrafiltration tubes (Centrifree YM-30, molecular weight cutoff, 30,000 Da; Millipore: Billerica, USA) and centrifuged at 1500g for 15 min. Equal aliquots (20 μL) of the ultrafiltrate (Cfree) and of the plasma (Ctotal) were counted for their radioactivity with a NaI gamma well-counter. The duplicate analysis was performed for each step. The free fraction was then calculated as fp = Cfree / Ctotal, and the results were corrected for the membrane binding measured with the control samples.
+ Open protocol
+ Expand
9

Plasma Protein Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To estimate the free fraction (fp) of the radioligands in the plasma, an ultrafiltration method was used. Approximately 1 MBq of [18F]d2, [18F]d4, [18F]d6, and [18F]d8 were added to 450 μL of Seronorm Human plasma (Invicon GmbH, Munich, Germany), and the mixture was incubated for 10 min. After incubation, 150 μL of plasma was transferred into 3 ultrafiltration tubes (Centrifree YM-30; cutoff 30,000 MW; Millipore) and centrifuged at 8,000 rpm for 10 min. Equal aliquots of the ultrafiltrate (Cfree), and of the plasma (Ctotal) were counted for their radioactivity with a γ-counter. The fp of the radioligands was calculated as fp = Cfree/Ctotal (n = 3).
+ Open protocol
+ Expand
10

Determination of Free Fraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma (500 μl) or phosphate-buffered saline solution (500 μl) as a control was mixed with the formulation (50 μl, ~ 1–5 MBq) and incubated at room temperature for 10 min. After the incubation, 200-μl portions of the incubation mixtures was pipetted into ultrafiltration tubes (Centrifree YM-30, molecular weight cutoff, 30,000; Millipore: Billerica, USA) and centrifuged at 1500g for 15 min. Equal aliquots (20 μl) of the ultrafiltrate (Cfree) and of the plasma (Ctotal) were counted for their radioactivity using a NaI well counter. Each determination was performed in duplicate. The free fraction was then calculated as fP=Cfree/Ctotal, and the results were corrected for the membrane binding measured with the control samples.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!